Timothy Hatlen to Adaptive Clinical Trials as Topic
This is a "connection" page, showing publications Timothy Hatlen has written about Adaptive Clinical Trials as Topic.
Connection Strength
0.054
-
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study. Lancet Microbe. 2024 06; 5(6):e559-e569.
Score: 0.054